Simulation of pharmacokinetic drug-drug interaction and dosage regimens optimization of nelfinavir and cepharanthine as a potential combination against COVID-19
The pharmacokinetic (PK) drug-drug interactions (DDIs) of nelfinavir and cepharanthine combination is limited information in human. In addition, the dosage regimen of this combination is not available for COVID-19 treatment. The objective of this study was to perform in silico simulations using Gast...
Saved in:
Main Author: | Nosoongnoen W. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82220 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
COVID-19: Potential Repurposing Drugs
by: Wattana Leowattana
Published: (2022) -
Antimalarial pharmacokinetics and treatment regimens.
by: NJ White
Published: (2018) -
Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
by: Kalayanee Chairat, et al.
Published: (2019) -
Clinical Pharmacokinetics of Antimalarial Drugs
by: Nicholas J. White
Published: (2018) -
Population pharmacokinetic properties of antituberculosis drugs in Vietnamese children with tuberculous meningitis
by: Navarat Panjasawatwong, et al.
Published: (2022)